PTPN22-CD45 dual phosphatase retrograde feedback enhances TCR signaling and autoimmunity.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 40911684.
- Also identified by DOI 10.1126/sciadv.adw2568 and PMC identifier 12412669.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Protein tyrosine phosphatase nonreceptor type 22 (PTPN22) is encoded by a gene strongly associated with lupus and other autoimmune diseases. PTPN22 regulates T cell receptor (TCR) signaling through dephosphorylation of the kinases lymphocyte-specific protein tyrosine kinase (LCK) and zeta-chain-associated protein kinase 70 (ZAP70). The regulation of PTPN22 remains poorly understood. Here, we identify PTPN22 Ser<sup>449</sup> as a protein kinase A phosphorylation site, which is triggered by TCR engagement and is hyperphosphorylated in lupus peripheral blood cells. PTPN22 Ser<sup>449</sup> phosphorylation selectively lowered the affinity of PTPN22 for ZAP70 versus LCK but also indirectly suppressed inhibitory LCK Tyr<sup>192</sup> phosphorylation through a ZAP70-CD45 signaling axis. The resulting dephosphorylation of LCK Tyr<sup>192</sup> not only enhanced TCR signaling but also modulated pathway activation downstream the TCR. In vivo loss of PTPN22 Ser<sup>449</sup> phosphorylation reduced T cell responses and suppressed experimental lupus nephritis. These results suggest that PTPN22 Ser<sup>449</sup> phosphorylation promotes a CD45-mediated retrograde ZAP70-LCK feedback loop that enhances T cell responses and promotes autoimmunity.
Medical subject headings
- Protein Tyrosine Phosphatase, Non-Receptor Type 22
- Leukocyte Common Antigens
- Receptors, Antigen, T-Cell
- Signal Transduction
- Autoimmunity
- Feedback, Physiological